logo
Book a meeting
Minovia Therapeutics

Minovia Therapeutics

Biotechnology, Haifa, Massachusetts, 02142, United States, 11-50 Employees

minoviatx.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +16*********

Who is MINOVIA THERAPEUTICS

Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as res...

Read More

lock icon Get Full Access
map
  • Haifa, Massachusetts, 02142, United States Headquarters: Haifa, Massachusetts, 02142, United States
  • 2012 Date Founded: 2012
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7389

checked-icon Does something look wrong? Fix it. | View contact records from MINOVIA THERAPEUTICS

Minovia Therapeutics Org Chart and Mapping

Employees
John Cox

John Cox

Executive Chairman

Rinat Marko

Rinat Marko

Senior Quality Assurance Specialist

See Full Org Chart arrow
email-formate-icon
View Email Formats for Minovia Therapeutics
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Minovia Therapeutics

Answer: Minovia Therapeutics's headquarters are located at Haifa, Massachusetts, 02142, United States

Answer: Minovia Therapeutics's phone number is +16*********

Answer: Minovia Therapeutics's official website is https://minoviatx.com

Answer: Minovia Therapeutics's revenue is $10 Million to $25 Million

Answer: Minovia Therapeutics's SIC: 7389

Answer: Minovia Therapeutics has 11-50 employees

Answer: Minovia Therapeutics is in Biotechnology

Answer: Minovia Therapeutics contact info: Phone number: +16********* Website: https://minoviatx.com

Answer: Minovia Therapeutics is a clinical-stage international biotechnology company, established in hopes to bring life changing therapies to patients with Mitochondrial diseases, as fast as responsible. Following compassionate use cases performed in Sheba Medical hospital in Israel, using our proprietary Mitochondrial Augmentation Therapy, Minovia is now conducting the first of its kind clinical trial for Pearson syndrome, an ultra-rare pediatric disease.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access